Irreversible airway obstruction in childhood asthma? A clinician's viewpoint

Pediatric Pulmonology
Peter König

Abstract

Even though childhood asthma is assumed to comprise reversible airway obstruction, some children develop irreversible airway obstruction (not reversed by a bronchodilator or corticosteroids); this may be due to inflammation that has caused remodeling. Lately, it has been claimed that in the absence of treatment with inhaled corticosteroids, most patients will develop progressive irreversible obstruction. Several studies culminating with the Childhood Asthma Management Program (CAMP) study, which was the first randomized placebo-controlled prospective long-term study designed to test for irreversible obstruction, did not show the development of such progressive irreversible obstruction. Nevertheless, deterioration in pulmonary function does occur in some patients, probably due to inadequate anti-inflammatory treatment, and possibly also due to maintenance adrenergic treatment. Most previous studies concentrated on forced expiratory volume in 1 sec (FEV(1)), a test assessing mostly large airway obstruction. More studies are needed to investigate the presence of small airway obstruction.

References

Jun 1, 1977·Australian Paediatric Journal·H E Williams, P D Phelan
Aug 1, 1977·Archives of Disease in Childhood·H Blair
Dec 8, 1990·Lancet·M R SearsG P Herbison
Jul 1, 1989·Archives of Disease in Childhood·J O WarnerM Silverman
Jul 1, 1988·The American Review of Respiratory Disease·W J KellyA Olinsky
May 11, 1968·British Medical Journal·J M Smith, G F Devey
Oct 1, 1983·Archives of Disease in Childhood·H R AndersonS West
Feb 1, 1984·Thorax·P J BrownK E Finucane
Jul 1, 1995·The Journal of Allergy and Clinical Immunology·D W CockcroftR Bhagat
Sep 15, 1994·The New England Journal of Medicine·T HaahtelaA Sovijärvi
Dec 1, 1996·The Journal of Allergy and Clinical Immunology·P König, J Shaffer
Jan 1, 1997·Pediatric Pulmonology·H OswaldA Olinsky
Oct 6, 1997·American Journal of Respiratory and Critical Care Medicine·A A VerberneK F Kerrebijn
May 1, 1998·The Journal of Allergy and Clinical Immunology·P J Barnes
Sep 14, 1999·The Journal of Allergy and Clinical Immunology·J E Fish, S P Peters
Oct 12, 2000·The New England Journal of Medicine·UNKNOWN Childhood Asthma Management Program Research GroupRobert Zeiger

❮ Previous
Next ❯

Citations

Dec 19, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Toru OgaMichiaki Mishima
Jan 30, 2004·Current Opinion in Pulmonary Medicine·Elisabeth H Bel
Sep 10, 2004·The Journal of Allergy and Clinical Immunology·Perla A VargasStacie M Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.